These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 9092214)
1. [Therapy approaches in cerebral cognitive deficits--neuropsychiatric aspects]. Reisecker F Wien Med Wochenschr; 1996; 146(21-22):546-8. PubMed ID: 9092214 [TBL] [Abstract][Full Text] [Related]
2. [Pharmacotherapy of Alzheimer dementia: therapy of cognitive symptoms--new results of clinical studies]. Heidrich A; Rösler M; Riederer P Fortschr Neurol Psychiatr; 1997 Mar; 65(3):108-21. PubMed ID: 9173033 [TBL] [Abstract][Full Text] [Related]
3. [Dementing disorders. What benefits do the new anti-dementia drugs have?]. Ihl R MMW Fortschr Med; 2002 May; Suppl 2():24-6, 28-9. PubMed ID: 12070846 [TBL] [Abstract][Full Text] [Related]
4. [Alzheimer drugs for mild cognitive impairment]. Fellgiebel A Neuropsychiatr; 2007; 21(3):230-3. PubMed ID: 17915184 [TBL] [Abstract][Full Text] [Related]
5. [Current antidementive therapy]. Perneczky R; Kurz A MMW Fortschr Med; 2004 May; 146 Spec No 2():53-6. PubMed ID: 15376702 [TBL] [Abstract][Full Text] [Related]
6. The pharmacological effects of ginkgo biloba, a plant extract, on the brain of dementia patients in comparison with tacrine. Itil TM; Eralp E; Ahmed I; Kunitz A; Itil KZ Psychopharmacol Bull; 1998; 34(3):391-7. PubMed ID: 9803773 [TBL] [Abstract][Full Text] [Related]
7. [Therapy of Alzheimer disease]. Kovács T Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816 [TBL] [Abstract][Full Text] [Related]
8. [Possibilities and limits of therapy of cognition disorders in the elderly]. Hoyer S Z Gerontol Geriatr; 1995; 28(6):457-62. PubMed ID: 8581765 [TBL] [Abstract][Full Text] [Related]
10. Clinical experience of galantamine in dementia: a series of case reports. Dale MC; Libretto SE; Patterson C; Anderson J; Choudhury T; McCafferty F; McWilliam C; Richardson M Curr Med Res Opin; 2003; 19(6):508-18. PubMed ID: 14594523 [TBL] [Abstract][Full Text] [Related]
11. Nootropics: pharmacological properties and therapeutic use. Gabryel B; Trzeciak HI Pol J Pharmacol; 1994; 46(5):383-94. PubMed ID: 7894524 [TBL] [Abstract][Full Text] [Related]
12. Dementia. Warner J; Butler R Clin Evid; 2002 Jun; (7):846-66. PubMed ID: 12230710 [No Abstract] [Full Text] [Related]
13. Dementia. Warner J; Butler R; Jackson E Clin Evid; 2002 Dec; (8):927-50. PubMed ID: 12603921 [No Abstract] [Full Text] [Related]
15. [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia]. Tariska P; Paksy A Orv Hetil; 2000 May; 141(22):1189-93. PubMed ID: 10853348 [TBL] [Abstract][Full Text] [Related]
16. Lines of therapeutics research in Alzheimer's disease. Shvaloff A; Neuman E; Guez D Psychopharmacol Bull; 1996; 32(3):343-52. PubMed ID: 8961777 [TBL] [Abstract][Full Text] [Related]
17. Treatment of impaired cognition with nootropic drugs: nicergoline versus the state of the art. Fariello RG Funct Neurol; 1997; 12(3-4):221-5. PubMed ID: 9218984 [No Abstract] [Full Text] [Related]
18. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials. Passmore AP; Bayer AJ; Steinhagen-Thiessen E J Neurol Sci; 2005 Mar; 229-230():141-6. PubMed ID: 15760632 [TBL] [Abstract][Full Text] [Related]
19. [Nootropic drugs and their action mechanisms in relation to the neuropathobiology of senile dementia. I. Neurotransmission disorders in the brain]. Benesová O Cesk Psychiatr; 1994 Aug; 90(4):191-200. PubMed ID: 7987928 [TBL] [Abstract][Full Text] [Related]